Chemical Genetics of Vertebrate Vascular Development
脊椎动物血管发育的化学遗传学
基本信息
- 批准号:7234118
- 负责人:
- 金额:$ 13.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-30 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAllelesAngioblastAortaBiologicalBiologyBlood VesselsCardiologyCardiovascular systemCell physiologyChemical StructureChemicalsClinicalDataDefectDetectionDevelopmentDevelopmental ProcessEmbryoEmbryonic arterial structureEndothelial CellsEvolutionFellowshipFluorescence MicroscopyGenesGeneticHumanIn VitroLY294002LeadLesionLightMEKsMediatingMethodsMolecularMolecular BiologyMolecular GeneticsMutationNumbersOrganogenesisPathway interactionsPhenotypePhosphatidylinositide 3-Kinase InhibitorPhosphoinositide-3-Kinase, Catalytic, Gamma PolypeptideProductionResearchResearch PersonnelResourcesRoleSeminalSeriesSignal PathwaySignal TransductionStagingStructureTechniquesTestingTissuesTrainingUmbilical veinVascular DiseasesVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth FactorsVeinsVenousWorkZebrafishangiogenesisbasechemical geneticsdevelopmental geneticsenhanced green fluorescent proteingenetic analysisgenetic manipulationin vivokinase inhibitormigrationmutantneutralizing antibodynotch proteinnovelprecursor cellprogenitorprogramsresearch studyresponseskillssmall moleculetoolvasculogenesis
项目摘要
DESCRIPTION (provided by applicant):
Understanding how the vertebrate circulatory system develops is a fundamental biological challenge with tremendous clinical implications. Molecular and genetic studies in zebrafish have highlighted the key roles of vascular endothelial growth factor (VEGF), Notch, and gridlock (grl) in the signaling pathway for embryonic vascular development. The zebrafish has proven to be remarkably amenable to chemical genetics analysis, in which small molecules discovered by high-throughput, phenotype-based screens are used as tools for dissecting cellular and developmental processes. Seminal work has recently identified a novel compound, GS4012, by virtue of its ability to suppress the vascular defect caused by a mutation in the grl gene. The grl suppressor screen has also identified another suppressor, GS4898, which has a completely different structure, and presumably distinct mechanism of action, from GS4012. This proposal takes molecular and chemical genetic approaches to study vertebrate vascular development, with three specific aims: 1) Determine how GS4012 rescues the gridlock vascular defect in mutant embryos. 2) Identify signaling pathways targeted by GS4012 in cultured endothelial cells. 3) Identify the mechanism of action of GS4898 in vivo and in vitro. This project will help to answer some of the outstanding questions regarding vasculogenesis and provide a valuable set of chemical tools for further study. Gridlock suppressors like GS4012 and GS4898, which modulate vascular development, may serve as lead compounds for treatments of important illnesses such ischemic vascular diseases.
The candidate, who has a background in molecular biology and developmental genetics, has recently completed cardiology fellowship training. Dr. Hong now seeks to expand upon his scientific skills through unique resources available at the MGH's Cardiovascular Research Center. His two sponsors will guide him in chemical genetics, zebrafish biology, and cardiovascular cellular physiology, as well as in professional development. Dr. Hong's panel of advisors includes leaders in the fields of angiogenesis, zebrafish organogenesis, and zebrafish hemangioblast development. Mechanism of action studies of GS4012, GS4898, and additional gridlock suppressors will serve as a springboard for further scientific development, culminating in Dr. Hong's emergence as an independent investigator in the field of basic vascular biology.
描述(由申请人提供):
了解脊椎动物循环系统如何发展是具有巨大临床意义的基本生物学挑战。 斑马鱼中的分子和遗传研究强调了血管内皮生长因子(VEGF),Notch和Gridlock(GRL)在胚胎血管发育的信号传导途径中的关键作用。事实证明,斑马鱼非常适合化学遗传学分析,其中通过高通量发现,基于表型的筛选被用作解剖细胞和发育过程的工具。 最近,开创性的工作确定了一种新型化合物GS4012,它抑制了由GRL基因突变引起的血管缺陷的能力。 GRL抑制器屏幕还确定了另一个抑制器GS4898,该抑制剂与GS4012具有完全不同的结构,也许是不同的作用机理。 该建议采用分子和化学遗传学方法来研究脊椎动物血管发育,三个具体目的:1)确定GS4012如何营救突变体胚胎中的僵局血管缺陷。 2)确定GS4012靶向的信号通路在培养的内皮细胞中。 3)确定GS4898在体内和体外的作用机理。 该项目将有助于回答有关血管生成的一些杰出问题,并为进一步研究提供一套宝贵的化学工具。 调节血管发育的GS4012和GS4898之类的僵局抑制剂可能是铅化合物,用于治疗重要疾病,例如缺血性血管疾病。
该候选人在分子生物学和发育遗传学方面具有背景,最近完成了心脏病学研究金培训。 Hong博士现在试图通过MGH的心血管研究中心获得的独特资源来扩展他的科学技能。 他的两个赞助商将指导他从事化学遗传学,斑马鱼生物学和心血管细胞生理学以及专业发展。 Hong博士的顾问小组包括血管生成,斑马鱼器官发生和斑马鱼血管细胞发育领域的领导者。 GS4012,GS4898和其他僵局抑制器的作用研究机制将成为进一步科学发展的跳板,最终导致了Hong博士在基本血管生物学领域的独立研究者的出现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES C HONG其他文献
CHARLES C HONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES C HONG', 18)}}的其他基金
Mechanistic Insights into The Role of Microtubule Organizing Centers on Cardiomyocyte Structure and Function
微管组织中心对心肌细胞结构和功能作用的机制见解
- 批准号:
10743120 - 财政年份:2023
- 资助金额:
$ 13.37万 - 项目类别:
Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome
增强心肌性能和改善心力衰竭结果的新方法
- 批准号:
10064633 - 财政年份:2017
- 资助金额:
$ 13.37万 - 项目类别:
Cardiac Induction by Small Molecule BMP Inhibitors
小分子 BMP 抑制剂的心脏诱导
- 批准号:
8690200 - 财政年份:2010
- 资助金额:
$ 13.37万 - 项目类别:
Cardiac Induction by Small Molecule BMP Inhibitors
小分子 BMP 抑制剂的心脏诱导
- 批准号:
7948340 - 财政年份:2010
- 资助金额:
$ 13.37万 - 项目类别:
Cardiac Induction by Small Molecule BMP Inhibitors
小分子 BMP 抑制剂的心脏诱导
- 批准号:
8257900 - 财政年份:2010
- 资助金额:
$ 13.37万 - 项目类别:
Cardiac Induction by Small Molecule BMP Inhibitors
小分子 BMP 抑制剂的心脏诱导
- 批准号:
8666797 - 财政年份:2010
- 资助金额:
$ 13.37万 - 项目类别:
Cardiac Induction by Small Molecule BMP Inhibitors
小分子 BMP 抑制剂的心脏诱导
- 批准号:
8461665 - 财政年份:2010
- 资助金额:
$ 13.37万 - 项目类别:
Regulation and Maintenance of Cardiac Muscle Sarcomere Integrity
心肌肌节完整性的调节和维持
- 批准号:
8688316 - 财政年份:2010
- 资助金额:
$ 13.37万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
- 批准号:
10590033 - 财政年份:2024
- 资助金额:
$ 13.37万 - 项目类别:
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 13.37万 - 项目类别:
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 13.37万 - 项目类别:
Drivers and consequences of introgression in evolution
进化中基因渗入的驱动因素和后果
- 批准号:
10552299 - 财政年份:2023
- 资助金额:
$ 13.37万 - 项目类别: